πŸ‡ΊπŸ‡Έ FDA
Patent

US 8648079

Heterocyclic compounds

granted A61PA61P25/00A61P25/14

Quick answer

US patent 8648079 (Heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/18